Regulatory and site milestones land alongside a sizable EPS beat

The quarter beat the limited published earnings bar, but not because the operating model suddenly improved. Reported diluted EPS was -$0.09 versus a published Q2 consensus of roughly -$0.51, although coverage appears thin and the estimate basis may not be directly comparable. The better-than-expected loss was helped by $2.5 million of interest and dividend income and essentially no interest expense, rather than revenue generation or a step-change in commercial activity.

The substantive positive is execution against the development roadmap. The NRC approved the Postulated Initiating Events methodology topical report, building on the earlier Principal Design Criteria approval; the company says these reports can be reused in future licensing applications without re-evaluation. It also secured site control over 77 acres at Texas A&M-RELLIS and signed agreements to continue site characterization and environmental work. These are genuine de-risking steps, but they advance licensing and site preparation rather than establish an operating plant, binding customer order, or commercial revenue stream. (Engineering and Regulatory Highlights; Commercial Pipeline of IMSR Plant Projects)

The raised economics improve the long-term story but remain management estimates, not realized performance. Lifetime revenue per plant increased 29%, to $2.7 billion, with 79% expected after construction through long-term Core-unit and Fuel Salt supply contracts; projected gross margins are 33% for Core-unit supply and 40% for Fuel Salt supply. The filing itself flags that these assumptions may prove incorrect, so the change is best read as a higher potential value case—not current earnings power. (Unit Economics Update; Forward-Looking Statements)

Liquidity is a meaningful cushion, while spending remains elevated versus last year. The company ended the quarter with $283.4 million in cash, cash equivalents and investments and reported a $6.4 million quarterly cash burn, with the lower burn attributed largely to testing timing. However, operating expenses were $11.7 million, more than double the year-ago level, and first-half operating cash use reached $14.8 million versus $6.9 million in the first half of 2025. No new financing was reported in the first half, and shares were broadly stable, which limits immediate dilution pressure but does not remove the need to fund a long development cycle. (Performance, Liquidity and Capital Structure; Statements of Cash Flows)

Net read: better than expected, with the improvement concentrated in milestones and reported EPS—not near-term commercialization. The filing delivers a clean regulatory milestone, site control, unchanged share count and a stronger company-generated economics case, while the earnings beat is partly financial-income-driven and the business remains pre-revenue with substantial execution, licensing and funding risks. That combination supports a mildly positive read versus the standing expectation, but it does not materially change the project's long lead time to commercial validation. (Exhibit 99.1; Statements of Operations and Comprehensive Loss; Forward-Looking Statements)